Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May;65(3):297-299.
doi: 10.1111/ajd.14248. Epub 2024 Mar 7.

Janus kinase inhibitor Abrocitinib as an Off-Label treatment for tattoo granuloma with uveitis (TAGU)

Yutong Yang  1 , Jia Yan  1 , Jin Yang  1 , Peiru Wang  1 , Yeqiang Liu  2 , Xiuli Wang  1
Affiliations
Case Reports

Janus kinase inhibitor Abrocitinib as an Off-Label treatment for tattoo granuloma with uveitis (TAGU)

Yutong Yang et al. Australas J Dermatol. 2024 May.
No abstract available

Keywords: Janus kinase inhibitor; abrocitinib; tattoo granuloma; uveitis.

PubMed Disclaimer

References

REFERENCES

    1. Kluger N. Tattoo‐associated uveitis with or without systemic sarcoidosis: a comparative review of the literature. J Eur Acad Dermatol Venereol. 2018;32(11):1852–1861. https://doi.org/10.1111/jdv.15070
    1. Maijer KI, van der Bent SAS, Vercoutere W, Rustemeyer T. Granulomatous tattoo reaction with associated uveitis successfully treated with methotrexate. J Eur Acad Dermatol Venereol. 2018;32(9):e338–e339. https://doi.org/10.1111/jdv.14854
    1. Peterson AS, Patterson AW. Case series: tattoo‐associated uveitis. Optom Vis Sci. 2022;99(4):383–388. https://doi.org/10.1097/opx.0000000000001859
    1. Chapman S, Gold LS, Lim HW. Janus kinase inhibitors in dermatology: part II. A comprehensive review. J Am Acad Dermatol. 2022;86(2):414–422. https://doi.org/10.1016/j.jaad.2021.06.873

LinkOut - more resources